The effect of steroid treatment with inhaled budesonide or intravenous methylprednisolone on phosgene-induced acute lung injury in a porcine model

Military Medicine

Volumn 174, Issue 12, 2009, Pages 1287-1294

  Smith, Adam ^a   Brown, Roger ^a   Jugg, Bronwen ^a   Piatt, Janet ^a   Mann, Thomas ^a   Masey, Charles ^a   Jenner, John ^a   Rice, Paul ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BUDESONIDE; CHEMICAL WARFARE AGENT; METHYLPREDNISOLONE; PHOSGENE;

ACUTE LUNG INJURY; ANIMAL; AREA UNDER THE CURVE; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; INHALATIONAL DRUG ADMINISTRATION; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; RANDOMIZATION; SWINE;

ACUTE LUNG INJURY; ADMINISTRATION, INHALATION; ANIMALS; AREA UNDER CURVE; BRONCHOALVEOLAR LAVAGE; BUDESONIDE; CHEMICAL WARFARE AGENTS; FEMALE; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INTERMITTENT POSITIVE-PRESSURE VENTILATION; METHYLPREDNISOLONE; PHOSGENE; RANDOM ALLOCATION; SWINE;

EID: 77449112231     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED-D-09-00050     Document Type: Article

References (31)

1. Sciuto AM, Hurl HH: Therapeutic treatments of phosgene-induced lung injury. Inhal Toxicol 2004: 16: 565-80.
2. Marrs TC, Maynard RJ, Sidell FR (editors) : Phosgene. In: Chemical Warfare Agents: Toxicology and Treatment, p 185. Chichester, John Wiley, 1996.
3. Diller WF: Pathogenesis of phosgene poisoning. Toxicol Ind Health 1985;1(2):7-15.
4. Brown RFR, Jugg BJA, Harban FMJ, et al: Pathophysiological responses following phosgene exposure in the anaesthetised pig. J Appl Toxicol 2002: 22: 263-9.
5. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000;342(18):1334-1349.
6. Hirche TO, Atkinson JJ, Bahr S, Belaaouaj A: Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites. Am J Respir Cell Mol Biol 2004;30(4):576-84.
7. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202(2):145-56.
8. Bassaris HP, Lianou PE, Mallioris KN, et al: Effects of methylprednisolone and dexamethasone on polymorphonuclear leukocyte adherence in vivo. Drags Exp Clin Res 1987;13(5):267-71.
9. Kimura T, Iwase M, Kondo G, et al: Suppressive effect of selective cyclooxygcnase-2 inhibitor on cytokine release in human neutrophils. Int Immunopharmacol 2003;3 (10-11) : 1519-28.
10. Jian MY, Koizumi T, Tsushima K, Kubo K: JTE-607, a cytokine release blocker, attenuates acid aspiration-induced lung injury in rats. Eur J Pharmacol 2004: 488 (1-3) : 231-238.
11. Nys M, Deby-Dupont G, Habraken Y, et al: Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NP-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines. Nitric Oxide 2003;9(1):33-43.
12. Pittet JF, Mackersie RC, Martin TR, and Matthay MA: Biological markers of acute lung injury and pathogenetic significance. Am.1 Respir Crit Care Med 1997;155(4):1187-1205.
13. Miotla JM, Jeffery PK, Hellewell PG: Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. Am J Respir Cell Mol Biol 1998;18(2):197-204.
14. Rosenberg GA: Matrix metalloproteinases in neuroinflammation. Glia 2002;39:279-91.
15. Powers KA, Woo J, Khadaroo RG, Papia G, Kapus A, Rotstein OD: Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery 2003;134(2):312-8.
16. Helman AS, Nathoo ZM, Lee HJ: Effects of new anti-inflammatory steroids derived from prednisolone on pituitary-adrenal axis and lysosomal stabilization. Drug Dev Res 1982;2:377-82.
17. Payne DNR. Adcock IM: Molecular mechanisms of corticosteroid actions. Paediatr Respir Rev 2001: 2: 145-50.
18. U. S. Army Medical Research Institute of Chemical Defense: Medical Management of Chemical Casualties Handbook, Ed 3, Aberdeen Proving Ground, MD, July, 2000.
19. Wang J, Winskog C, Edslon E, Walther SM: Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs. Acta Anaesthesiol Scand 2005;49(2):183-90.
20. Ashley Z, Jugg B, Brown R, et al: Effects of inhaled nitric oxide on the anaesthetised, mechanically ventilated, large white pig. Inhal Toxicol 2002;14:1175-85.
21. Parkhouse DA, Brown RF, Jugg BJ, et al: Protective ventilation strategies in the management of phosgene-induced acute lung injury. Milit Med 2007;172(3):295-300.
22. Parker SJ, Hill PF, Brown D, Kenward CE, Watkins PE: A porcine model of sepsis resulting from combined insults of haemorrhage and peritonitis. Shock 2000: 13:291-6.
23. Edwards JD, Shoemaker WC, Vincent J-L: Oxygen Transport: Principles and Practice, Appendix 2. London, WB Saunders, 1993.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. Altman DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1991.
26. The Acute Respiratory Distress Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and acute respiratory distress syndrome. N Engl J Med 2000: 324: 1301-8.
27. Sciuto AM, Stotts RR, Hurt HH: Efficiency of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury. J Appl Toxicol 1996;16(5):381-4.
28. Ghio A. I, Kennedy TP, Hatch GE, Teppcr JS: Reduction of neutrophil influx diminishes lung injury and mortality following phosgene inhalation. J Appl Physiol 1991;71(2):657-65.
29. Hafezi-Moghadam A, Simoncini T, Yang Z, et al: Acute cardiovascular protective effects of corticosteroids are medialed by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002: 8: 473-9.
30. La M, D'Amico M, Silvio B, et al: Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J 2001;15:2247-56.
31. Zingarelli B, Hake PW, Yany Z, O'Connor M, Denenberg A, Wong HR: Absence of inducible nitric oxide synthase modulates early reperfusioninduced NP-Kb and AP-1 activation and enhances myocardial damage. FASEB J 2002: 16: 327-42.